141 related articles for article (PubMed ID: 17034933)
41. A slippery preventive slope.
Justman S
Hastings Cent Rep; 2009; 39(2):49. PubMed ID: 19388386
[No Abstract] [Full Text] [Related]
42. High-grade prostate cancer and the prostate cancer prevention trial.
Logothetis CJ; Schellhammer PF
Cancer Prev Res (Phila); 2008 Aug; 1(3):151-2. PubMed ID: 19138948
[No Abstract] [Full Text] [Related]
43. [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].
Villers A
Prog Urol; 2008 Apr; 18 Suppl 3():S58-62. PubMed ID: 18455086
[TBL] [Abstract][Full Text] [Related]
44. Chemoprevention of prostate cancer with finasteride.
Thompson I; Feigl P; Coltman C
Important Adv Oncol; 1995; ():57-76. PubMed ID: 7672814
[No Abstract] [Full Text] [Related]
45. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
Kaplan SA
J Urol; 2014 Feb; 191(2):359. PubMed ID: 24411852
[No Abstract] [Full Text] [Related]
46. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
Seftel AD
J Urol; 2014 Feb; 191(2):359. PubMed ID: 24411851
[No Abstract] [Full Text] [Related]
47. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
Taneja SS
J Urol; 2014 Feb; 191(2):358. PubMed ID: 24411850
[No Abstract] [Full Text] [Related]
48. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
[TBL] [Abstract][Full Text] [Related]
49. Prostate cancer prevention trials in the USA.
Brawley OW; Parnes H
Eur J Cancer; 2000 Jun; 36(10):1312-5. PubMed ID: 10882873
[TBL] [Abstract][Full Text] [Related]
50. Prevention of prostate cancer with finasteride.
Rubin MA; Kantoff PW
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14561801
[No Abstract] [Full Text] [Related]
51. Chemoprevention for prostate cancer: the Prostate Cancer Prevention Trial.
Fitzpatrick JM
BJU Int; 2003 Sep; 92(4):339-40. PubMed ID: 12930412
[No Abstract] [Full Text] [Related]
52. Long-term survival of participants in the prostate cancer prevention trial.
Silberstein JL; Sartor O
Asian J Androl; 2014; 16(3):413-4. PubMed ID: 24625877
[TBL] [Abstract][Full Text] [Related]
53. Finasteride for chemoprevention of prostate cancer: why has it not been embraced?
de Vere White RW
J Clin Oncol; 2007 Jul; 25(21):2999-3000. PubMed ID: 17634478
[No Abstract] [Full Text] [Related]
54. Re: Long-term survival of participants in the Prostate Cancer Prevention Trial.
Thompson IM; Tangen CM; Goodman PJ
Asian J Androl; 2014; 16(3):414. PubMed ID: 24914438
[No Abstract] [Full Text] [Related]
55. High-grade prostate cancer and finasteride.
Lebdai S; Bigot P; Azzouzi AR
BJU Int; 2010 Feb; 105(4):456-9. PubMed ID: 19930174
[TBL] [Abstract][Full Text] [Related]
56. Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.
Barton MK
CA Cancer J Clin; 2011; 61(1):1-2. PubMed ID: 21199914
[No Abstract] [Full Text] [Related]
57. The clinical implications of the Prostate Cancer Prevention Trial (PCPT).
Pitts WR
BJU Int; 2004 May; 93(7):1120-1. PubMed ID: 15142187
[No Abstract] [Full Text] [Related]
58. Selections from current literature: androgenetic alopecia: the science behind a new oral treatment.
Baumann LS; Kelso EB
Fam Pract; 1998 Oct; 15(5):493-6. PubMed ID: 9848437
[No Abstract] [Full Text] [Related]
59. Prostate cancer: mortality unaffected by finasteride treatment.
Payton S
Nat Rev Urol; 2013 Oct; 10(10):551. PubMed ID: 24018566
[No Abstract] [Full Text] [Related]
60. [Dual 5-alpha reductase inhibitors in BPH (benign prostatic hyperplasia). Already after 1 month prostate shrinks].
MMW Fortschr Med; 2003 Feb; 145(9):54. PubMed ID: 12666533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
